THE CLINICAL-VALUE OF URINARY POLYAMINE ANALYSES IN CANCER-PATIENTS
- 1 January 1980
- journal article
- research article
- Vol. 1 (4-5) , 215-225
Abstract
The polyamines, putrescine (P) and spermidine (S), were measured in 185 cancer patients. Patients in remission exhibited significantly different levels from those with active disease. In a dynamic patient study, followed over 5-6 mo., the urinary polyamine levels correlated closely with the clinical status. Polyamines were measured 24 h before beginning chemotherapy (P1, S1) and 48 h after its onset (P2, S2). The value of the ratio, (S2/P2)/(S1/P1), correlated with the type of response to chemotherapy.This publication has 8 references indexed in Scilit:
- PREDICTIVE VALUE OF CEREBROSPINAL-FLUID POLYAMINES IN MEDULLOBLASTOMA1979
- Automated analysis of common basic amino acids, mono-, di-, and polyamines, phenolicamines, and indoleamines in crude biological samplesAnalytical Biochemistry, 1978
- A quantitative approach to determining disease response during therapy using multiple biologic markers.Application to carcinoma of the breastCancer, 1978
- Polyamines in rapid growth and cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1978
- POLYAMINES AS MARKERS OF RESPONSE AND DISEASE ACTIVITY IN CANCER CHEMOTHERAPY1977
- Urinary polyamine levels in patients with localized malignancyCancer, 1976
- tRNA methyltransferases from rat liver. Differences in response of partially purified enzymes to polyamines and inorganic saltsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1976
- DISTRIBUTION OF SPERMIDINE AND SPERMINE IN BLOOD FROM CYSTIC-FIBROSIS PATIENTS AND CONTROL SUBJECTS1976